Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Endocrinology"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Diabetes, obesity and metabolism
Antilipolytic Insulin Sensitivity Indices Measured during an Oral Glucose Challenge: Associations with Insulin-Glucose Clamp and Central Adiposity in Women without Diabetes
Foued Naimi, Christophe Richer dit Laflèche, Marie-Claude Battista, André C. Carpentier, Jean-Patrice Baillargeon
Endocrinol Metab. 2025;40(4):561-573.   Published online March 18, 2025
DOI: https://doi.org/10.3803/EnM.2024.2129
  • 4,229 View
  • 86 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Tissue overexposure to non-esterified fatty acids (NEFA) contributes to the development of metabolic conditions, with insulin-mediated suppression of lipolysis being an important mechanism in limiting this overexposure. We investigated which dynamic NEFA insulin-suppression indices derived from the oral glucose tolerance test (OGTT) were best associated with those derived from the insulin-glucose clamp, as well as with central adiposity and glucoregulatory parameters.
Methods
This cross-sectional study recruited 29 women without diabetes, 15 healthy women, and 14 women with polycystic ovary syndrome. The OGTT indices of NEFA insulin-suppression were the decremental NEFA area under the curve, negative log-linear NEFA slope, percentage of NEFA suppression (%NEFAsupp) and time to suppress NEFA levels by 50% (T50NEFA). The indices derived from the two-step euglycemic-hyperinsulinemic clamp (low-dose insulin step) were delta NEFA and %NEFAsupp.
Results
Among the OGTT and clamp indices, T50NEFA[OGTT] and %NEFAsupp[clamp] showed the closest associations in both subgroups (r=–0.58). Additionally, T50NEFA correlated significantly in all women with waist circumference (r=0.64), body fat percentage (r=0.60), fasting insulinemia (r=0.53), and M-value insulin sensitivity index (r=–0.45). Similarly, %NEFAsupp[clamp] correlated significantly in all women with waist circumference (r=–0.57), body fat percentage (r=–0.54), fasting insulinemia (r=–0.55), and M-value insulin sensitivity index (r=0.51). T50NEFA and %NEFAsupp[clamp] also correlated with other anthropometric and metabolic parameters associated with lipotoxicity.
Conclusion
For dynamic testing of NEFA insulin-suppression in women, T50NEFA was the OGTT-derived index best correlated with a clamp index (%NEFAsupp). These indices were also the most closely associated with anthropometric and glucoregulatory parameters. Thus, the OGTT-derived T50NEFA appears valid for assessing dynamic antilipolytic insulin action.

Citations

Citations to this article as recorded by  
  • Effects of Dietary Spirulina Supplementation on Cecal Microbiota, Serum Biochemistry, and Antioxidant Capacity in Lambs
    Yuxuan Wang, Yushan Jia, Gentu Ge, Jian Bao, Xia Ding, Xiangdong Liu, Zhijun Wang
    Microorganisms.2026; 14(2): 288.     CrossRef
  • From Adipose Dysfunction to Multi-Organ Steatosis: Defining the Metabolic Steatotic Axis
    Almir Fajkić, Yun Wah Lam, Rijad Jahić, Ivan Ćavar, Antonio Markotić, Andrej Belančić
    Current Issues in Molecular Biology.2026; 48(2): 178.     CrossRef
  • Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD
    Xi-Shuang Chen, Hui-Zhen Liu, Fang Huang, Jian Meng, Jing-Xian Fang, Yu Han, Hui-Ming Zou, Qing Gu, Xue Hu, Qian-Wen Ma, Yue-Xia Han, Sui-Jun Wang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
Close layer
Thyroid
TSHR Gene (rs179247) Polymorphism and Susceptibility to Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis
Hendra Zufry, Timotius Ivan Hariyanto
Endocrinol Metab. 2024;39(4):603-614.   Published online August 1, 2024
DOI: https://doi.org/10.3803/EnM.2024.1987
  • 8,089 View
  • 192 Download
  • 2 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Both Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are classified as autoimmune thyroid diseases (AITDs). It has been hypothesized that changes in the thyroid-stimulating hormone receptor (TSHR) gene may contribute to the development of these conditions. This study aimed to analyze the correlation between the TSHR rs179247 gene polymorphism and susceptibility to AITD.
Methods
We conducted a thorough search of the Google Scholar, Scopus, Medline, and Cochrane Library databases up until March 2, 2024, utilizing a combination of relevant keywords. This review examines data on the association between TSHR rs179247 and susceptibility to AITD. Random-effect models were employed to assess the odds ratio (OR), and the findings are presented along with their respective 95% confidence intervals (CIs).
Results
The meta-analysis included 12 studies. All genetic models of the TSHR rs179247 gene polymorphism were associated with an increased risk of developing GD. Specifically, the associations were observed in the dominant model (OR, 1.65; P<0.00001), recessive model (OR, 1.65; P<0.00001), as well as for the AA genotype (OR, 2.09; P<0.00001), AG genotype (OR, 1.39; P<0.00001), and A allele (OR, 1.44; P<0.00001). Further regression analysis revealed that these associations were consistent regardless of the country of origin, sample size, age, and sex distribution. However, no association was found between TSHR rs179247 and the risk of HT across all genetic models.
Conclusion
This study suggests that the TSHR rs179247 gene polymorphism is associated with an increased risk of GD, but not with HT, and may therefore serve as a potential biomarker.

Citations

Citations to this article as recorded by  
  • Genetic Risk Factors in Autoimmune Thyroid Diseases: An Umbrella Review of Meta-Analyses and Evidence Credibility
    Anu Shibi Anilkumar, Nithya Ajay, Ramakrishnan Veerabathiran
    Immunological Investigations.2026; 55(5): 1054.     CrossRef
Close layer
Review Articles
Miscellaneous
Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
Aliya Lakhani, Da Hyun Kang, Yea Eun Kang, Junyoung O. Park
Endocrinol Metab. 2023;38(6):619-630.   Published online November 21, 2023
DOI: https://doi.org/10.3803/EnM.2023.1814
  • 11,257 View
  • 218 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   ePub   
Metabolism is a dynamic network of biochemical reactions that support systemic homeostasis amidst changing nutritional, environmental, and physical activity factors. The circulatory system facilitates metabolite exchange among organs, while the endocrine system finely tunes metabolism through hormone release. Endocrine disorders like obesity, diabetes, and Cushing’s syndrome disrupt this balance, contributing to systemic inflammation and global health burdens. They accompany metabolic changes on multiple levels from molecular interactions to individual organs to the whole body. Understanding how metabolic fluxes relate to endocrine disorders illuminates the underlying dysregulation. Cancer is increasingly considered a systemic disorder because it not only affects cells in localized tumors but also the whole body, especially in metastasis. In tumorigenesis, cancer-specific mutations and nutrient availability in the tumor microenvironment reprogram cellular metabolism to meet increased energy and biosynthesis needs. Cancer cachexia results in metabolic changes to other organs like muscle, adipose tissue, and liver. This review explores the interplay between the endocrine system and systems-level metabolism in health and disease. We highlight metabolic fluxes in conditions like obesity, diabetes, Cushing’s syndrome, and cancers. Recent advances in metabolomics, fluxomics, and systems biology promise new insights into dynamic metabolism, offering potential biomarkers, therapeutic targets, and personalized medicine.

Citations

Citations to this article as recorded by  
  • Development and validation of an interpretable machine learning model for predicting intraoperative HDI in PPGL based on intratumoral and peritumoral CT radiomics
    Shurong Li, Zhiqiang Zhang, Yubing Zhang, Yulong Chen, Jian Ling, Qingfen Hong, Xuanling Wu, Fufu Zheng, Cheng Luo
    European Journal of Radiology.2026; 195: 112559.     CrossRef
  • Features of bioenergetic metabolism in physiological and pathological conditions: focus on oncogenesis
    A. S. Zhdanova, Z. E. Belaya, G. A. Melnichenko
    Problems of Endocrinology.2026; 71(6): 56.     CrossRef
  • Advances in Intestinal Glucose Absorption Regulation for Ruminant Energy Efficiency Improvement
    Yan Ye, Xiongfei Zhang, Junhu Yao, Xinjian Lei
    Animals.2026; 16(4): 659.     CrossRef
  • Factors Associated with the Development of Skin Lesions in Hospitalized Patients Admitted to a Nursing Preventive Care Program in Colombia
    Gaby E. Escobar, Ángela F Espinosa, Olga L. Cortés, Nicolás Molano González
    Investigación y Educación en Enfermería.2025;[Epub]     CrossRef
  • Editorial: Tumor metabolism and programmed cell death
    Dan-Lan Pu, Qi-Nan Wu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies
    Han Wang, Yang Liu, Aifa Tang, Xiansheng Zhang
    European Journal of Medical Research.2024;[Epub]     CrossRef
Close layer
Miscellaneous
Machine Learning Applications in Endocrinology and Metabolism Research: An Overview
Namki Hong, Heajeong Park, Yumie Rhee
Endocrinol Metab. 2020;35(1):71-84.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.71
  • 22,366 View
  • 261 Download
  • 22 Web of Science
  • 23 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   

Machine learning (ML) applications have received extensive attention in endocrinology research during the last decade. This review summarizes the basic concepts of ML and certain research topics in endocrinology and metabolism where ML principles have been actively deployed. Relevant studies are discussed to provide an overview of the methodology, main findings, and limitations of ML, with the goal of stimulating insights into future research directions. Clear, testable study hypotheses stem from unmet clinical needs, and the management of data quality (beyond a focus on quantity alone), open collaboration between clinical experts and ML engineers, the development of interpretable high-performance ML models beyond the black-box nature of some algorithms, and a creative environment are the core prerequisites for the foreseeable changes expected to be brought about by ML and artificial intelligence in the field of endocrinology and metabolism, with actual improvements in clinical practice beyond hype. Of note, endocrinologists will continue to play a central role in these developments as domain experts who can properly generate, refine, analyze, and interpret data with a combination of clinical expertise and scientific rigor.

Citations

Citations to this article as recorded by  
  • Facial Analysis in Acromegaly Using Machine Learning: Toward Earlier Diagnosis
    Banu Betul Kocaman, Oguzhan Recep Akkol, Gonenc Onay, Ayyuce Begum Bektas, Serdar Sahin, Ilkin Muradov, Lala Soltanova, Sabriye Sibel Taze, Zehra Kara, Hande Mefkure Ozkaya, Mouloud Adel, Pinar Kadioglu
    The Journal of Clinical Endocrinology & Metabolism.2026; 111(3): e892.     CrossRef
  • Advances in Machine Learning and Deep Learning for Hormonal Disorder Diagnosis: an Exhaustive Review on PCOS, Thyroid, and Optimization Techniques
    Sanjay Dhanka, Ankur Kumar, Abhinav Sharma, Haswanth Vundavilli, Surita Maini, Elakkiya Rajasekar
    Archives of Computational Methods in Engineering.2026; 33(2): 2785.     CrossRef
  • Microplastics and the Endocrine–Metabolic Interface: Novel Diagnostic Tools Targeting Thyroid–Adipose Axis
    Sunday Amos Onikanni, Babasola Aiyeku, Marjorie Dardis Murucci, Temitope Aribigbola, Kenia Bispo, Oluwatosin Stella Olayinka, Rômulo Sperduto Dezonne, Sara Gemini Piperni, Paula Soares, Denise Pires de Carvalho, Leandro Miranda‐Alves
    Environmental Toxicology.2026;[Epub]     CrossRef
  • Integration of Federated Learning and Blockchain in Health Care: Tutorial on Medical Data, Architectures, Privacy, Security, and Regulatory Compliance
    Yahya Shahsavari, Yaser Baseri, Abdelhakim Hafid, Oussama Abderrahmane Dambri, Dimitrios Makrakis
    Journal of Medical Internet Research.2026; 28: e80178.     CrossRef
  • Enhancing diagnostic accuracy of thyroid nodules: integrating self-learning and artificial intelligence in clinical training
    Daham Kim, Yoon-a Hwang, Youngsook Kim, Hye Sun Lee, Eunjung Lee, Hyunju Lee, Jung Hyun Yoon, Vivian Youngjean Park, Miribi Rho, Jiyoung Yoon, Si Eun Lee, Jin Young Kwak
    Endocrine.2025; 88(3): 766.     CrossRef
  • Harnessing machine learning for improved diagnosis, drug discovery, and patient care
    Jibon Kumar Paul, Mahir Azmal, Omar Faruk Talukder, ANM Shah Newaz Been Haque, Meghla Meem, Ajit Ghosh
    Computational and Structural Biotechnology Reports.2025;[Epub]     CrossRef
  • Revolutionizing healthcare with 5 G and AI: Integrating emerging technologies for personalized care and cancer management
    Abhishek Kumar, Jagat Pal Yadav, Shubhrat Maheshwari, Aditya Singh, Vineet Srivastava, Habibullah Khalilullah, Amita Verma
    Intelligent Hospital.2025; 1(1): 100005.     CrossRef
  • An approach to design deep homogeneous ensembles for the monitoring and prediction of blood glucose level
    Mohamed Zaim Wadghiri, Ali Idri
    International Journal of System Assurance Engineering and Management.2025; 16(9): 2931.     CrossRef
  • Establishment of a risk prediction model for olfactory disorders in patients with transnasal pituitary tumors by machine learning
    Min Chen, Yuxin Li, Sumei Zhou, Linbo Zou, Lei Yu, Tianfang Deng, Xian Rong, Shirong Shao, Jijun Wu
    Scientific Reports.2024;[Epub]     CrossRef
  • Application of artificial intelligence in ultrasound diagnostics of thyroid nodules
    E. A. Troshina, S. M. Zakharova, K. V. Tsyguleva, I. A. Lozhkin, D. V. Korolev, A. A. Trukhin, K. S. Zaytsev, T. V. Soldatova, A. A. Garmash
    Clinical and experimental thyroidology.2024; 20(1): 15.     CrossRef
  • Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes
    Jingtong Huang, Andrea M. Yeung, David G. Armstrong, Ashley N. Battarbee, Jorge Cuadros, Juan C. Espinoza, Samantha Kleinberg, Nestoras Mathioudakis, Mark A. Swerdlow, David C. Klonoff
    Journal of Diabetes Science and Technology.2023; 17(1): 224.     CrossRef
  • Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1
    William F. Simonds
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Application of machine learning and artificial intelligence in the diagnosis and classification of polycystic ovarian syndrome: a systematic review
    Francisco J. Barrera, Ethan D.L. Brown, Amanda Rojo, Javier Obeso, Hiram Plata, Eddy P. Lincango, Nancy Terry, René Rodríguez-Gutiérrez, Janet E. Hall, Skand Shekhar
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial
    Satoshi Ebata, Koji Oba, Kosuke Kashiwabara, Keiko Ueda, Yukari Uemura, Takeyuki Watadani, Takemichi Fukasawa, Shunsuke Miura, Asako Yoshizaki-Ogawa, Asano Yoshihide, Ayumi Yoshizaki, Shinichi Sato
    Rheumatology.2022; 61(11): 4364.     CrossRef
  • Automating and improving cardiovascular disease prediction using Machine learning and EMR data features from a regional healthcare system
    Qi Li, Alina Campan, Ai Ren, Wael E. Eid
    International Journal of Medical Informatics.2022; 163: 104786.     CrossRef
  • An Interactive Online App for Predicting Diabetes via Machine Learning from Environment-Polluting Chemical Exposure Data
    Rosy Oh, Hong Kyu Lee, Youngmi Kim Pak, Man-Suk Oh
    International Journal of Environmental Research and Public Health.2022; 19(10): 5800.     CrossRef
  • Ensemble blood glucose prediction in diabetes mellitus: A review
    M.Z. Wadghiri, A. Idri, Touria El Idrissi, Hajar Hakkoum
    Computers in Biology and Medicine.2022; 147: 105674.     CrossRef
  • The maze runner: navigating through basic kinetics to AI models of human metabolism pathology
    Arina V. Martyshina, Oksana M. Tilinova, Anastasia A. Simanova, Olga S. Knyazeva, Irina V. Dokukina
    Procedia Computer Science.2022; 213: 271.     CrossRef
  • Applications of Machine Learning in Bone and Mineral Research
    Sung Hye Kong, Chan Soo Shin
    Endocrinology and Metabolism.2021; 36(5): 928.     CrossRef
  • Facial Recognition Intensity in Disease Diagnosis Using Automatic Facial Recognition
    Danning Wu, Shi Chen, Yuelun Zhang, Huabing Zhang, Qing Wang, Jianqiang Li, Yibo Fu, Shirui Wang, Hongbo Yang, Hanze Du, Huijuan Zhu, Hui Pan, Zhen Shen
    Journal of Personalized Medicine.2021; 11(11): 1172.     CrossRef
  • The Application of Artificial Intelligence and Machine Learning in Pituitary Adenomas
    Congxin Dai, Bowen Sun, Renzhi Wang, Jun Kang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Real World Data and Artificial Intelligence in Diabetology
    Kwang Joon Kim
    The Journal of Korean Diabetes.2020; 21(3): 140.     CrossRef
  • A Novel Detection Framework for Detecting Abnormal Human Behavior
    Chengfei Wu, Zixuan Cheng, Yi-Zhang Jiang
    Mathematical Problems in Engineering.2020; 2020: 1.     CrossRef
Close layer
Adrenal gland
Is Follow-up of Adrenal Incidentalomas Always Mandatory?
Giuseppe Reimondo, Alessandra Muller, Elisa Ingargiola, Soraya Puglisi, Massimo Terzolo
Endocrinol Metab. 2020;35(1):26-35.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.26
  • 15,952 View
  • 310 Download
  • 15 Web of Science
  • 16 Crossref
AbstractAbstract PDFPubReader   ePub   

Adrenal masses are mainly detected unexpectedly by an imaging study performed for reasons unrelated to any suspect of adrenal diseases. Such masses are commonly defined as “adrenal incidentalomas” and represent a public health challenge because they are increasingly recognized in current medical practice. Management of adrenal incidentalomas is currently matter of debate. Although there is consensus on the need of a multidisciplinary expert team evaluation and surgical approach in patients with significant hormonal excess and/or radiological findings suspicious of malignancy demonstrated at the diagnosis or during follow-up, the inconsistency between official guidelines and the consequent diffuse uncertainty on management of small adrenal incidentalomas still represents a considerable problem in terms of clinical choices in real practice. The aim of the present work is to review the proposed strategies on how to manage patients with adrenal incidentalomas that are not candidates to immediate surgery. The recent European Society of Endocrinology/European Network for the Study of Adrenal Tumors guidelines have supported the view to avoid surveillance in patients with clear benign adrenal lesions <4 cm and/or without any hormonal secretion; however, newer prospective studies are needed to confirm safety of this strategy, in particular in younger patients.

Citations

Citations to this article as recorded by  
  • Beyond the norm: Exploring the diverse facets of adrenal lesions
    Sadaf Afif, Zoya Mahmood, Atif Zaheer, Javad R. Azadi
    Current Problems in Diagnostic Radiology.2026; 55(1): 137.     CrossRef
  • Incidental Adrenal Nodules and Growth Rates: A Single Centre Retrospective Cohort Study
    Julie Hu, Remy Lim, Mark Bolland
    Journal of Medical Imaging and Radiation Oncology.2026; 70(1): 50.     CrossRef
  • Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion?
    Martina Romanisio, Chiara Mele, Sara Sturnia, Carola Ciamparini, Rosa Pitino, Alice Ferrero, Lorenza Scotti, Madalina Elena Iftimie, Gianluca Aimaretti, Paolo Marzullo, Flavia Prodam, Marina Caputo
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Imaging of Adrenal Incidentalomas: What Actually Happens in Everyday Clinical Practice?
    Brian Ngo, Tracy Liu, Eddie Lau
    Journal of Medical Imaging and Radiation Oncology.2025; 69(3): 328.     CrossRef
  • The Landmark Series: Evaluation and Management of Adrenal Incidentalomas
    Lily Owei, Heather Wachtel
    Annals of Surgical Oncology.2025; 32(7): 4712.     CrossRef
  • Prolonged symptom duration and the potential for gradual progression in pediatric adrenocortical tumors: observations from the MET studies
    Michaela Kuhlen, Stefan A. Wudy, Clara Baumann, Christian Vokuhl, Michaela F. Hartmann, Marina Kunstreich, Rainer Claus, Antje Redlich
    Journal of Pediatric Endocrinology and Metabolism.2025; 38(9): 931.     CrossRef
  • Long-Term Follow-Up of Adrenal Incidentalomas: A Portuguese Single-Center Study
    David Veríssimo, Beatriz Pereira, Joana Rodrigues, Catarina Ivo, Ana Cláudia Martins, João Nunes e Silva, Dolores Passos, Luís Lopes, João Jácome de Castro, Mafalda Marcelino
    Endocrinology Insights.2025; 20(2): 67.     CrossRef
  • Mineral Metabolism Assays, Central DXA, and Fracture Risk Probabilities in Menopausal Patients with Non-Functional Adrenal Tumors with/Without Mild Autonomous Cortisol Secretion: Does the Presence of Unilateral Versus Bilateral Tumors Matter?
    Alexandra-Ioana Trandafir, Mara Carsote, Mihai Costachescu, Oana-Claudia Sima, Alexandru-Florin Florescu
    Life.2025; 15(10): 1639.     CrossRef
  • Case of adrenocortical cancer eleven years after diagnosis of adrenocortical adenoma
    Aleksandr A. Lisitsyn, Vyacheslav P. Zemlianoy, Vadim I. Mazurov, Ludmila I. Velikanova, Irina A. Bekhtereva
    Kazan medical journal.2025; 106(6): 1023.     CrossRef
  • Adrenal Incidentaloma—Innocent Bystander or Intruder?
    Laurence Amar, Inga Harbuz-Miller, Adina F Turcu
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1303.     CrossRef
  • Mineral metabolism assays and osteoporotic fracture risk evaluation in menopausal population diagnosed with adrenal incidentalomas: a sub-analysis of PRECES study
    Alexandra-Ioana Trandafir, Mihaela Stanciu, Ana Valea, Oana-Claudia Sima, Claudiu Nistor, Mădălina Gabriela Iliescu, Ileana Ciobanu, Florina Ligia Popa, Mara Carsote
    Balneo and PRM Research Journal.2024; 15(Vol.15, no): 692.     CrossRef
  • Diagnosing and managing adrenal incidentalomas
    Justine Herndon, Irina Bancos
    JAAPA.2023; 36(5): 12.     CrossRef
  • Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?
    M. Caputo, T. Daffara, A. Ferrero, M. Romanisio, E. Monti, C. Mele, M. Zavattaro, S. Tricca, A. Siani, A. Clemente, C. Palumbo, S. De Cillà, A. Carriero, A. Volpe, P. Marzullo, G. Aimaretti, F. Prodam
    Journal of Endocrinological Investigation.2023; 47(2): 377.     CrossRef
  • The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives
    Maja Mizdrak, Tina Tičinović Kurir, Joško Božić
    Biomedicines.2021; 9(2): 174.     CrossRef
  • An Adrenocortical Carcinoma Evolving After Nine Years of Latency From a Small Adrenal Incidentaloma
    Harpreet S Kohli, Sukesh Manthri, Shikha Jain, Rahul Kashyap, Sheng Chen, Thoyaja Koritala, Aysun Tekin, Ramesh Adhikari, Raghavendra Tirupathi, Aram Barbaryan, Simon Zec, Hanyin Wang, Stephanie Welle, Pavan Devulapally, Mack Sheraton, Manpreet Kaur, Vish
    Cureus.2021;[Epub]     CrossRef
  • Diagnostic algorithm of the subclinical forms of adrenal neoplasms
    Sofya G. Blyumina, Pavel N. Romashchenko, Igor S. Zheleznyak
    Bulletin of the Russian Military Medical Academy.2021; 23(3): 67.     CrossRef
Close layer
Miscellaneous
Search for Novel Mutational Targets in Human Endocrine Diseases
So Young Park, Myeong Han Seo, Sihoon Lee
Endocrinol Metab. 2019;34(1):23-28.   Published online March 21, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.1.23
  • 7,485 View
  • 99 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   

The identification of disease-causing genetic variations is an important goal in the field of genetics. Advancements in genetic technology have changed scientific knowledge and made it possible to determine the basic mechanism and pathogenesis of human disorders rapidly. Many endocrine disorders are caused by genetic variations of a single gene or by mixed genetic factors. Various genetic testing methods are currently available, enabling a more precise diagnosis of many endocrine disorders and facilitating the development of a concrete therapeutic plan. In this review article, we discuss genetic testing technologies for genetic endocrine disorders, with relevant examples. We additionally describe our research on implementing genetic analysis strategies to identify novel causal mutations in hypocalcemia-related disorders.

Citations

Citations to this article as recorded by  
  • A novel gain-of-function mutation (W818R) of calcium-sensing receptor in a family with autosomal dominant hypocalcemia type 1
    Min Fu, Yanxiang Luo, Kexin Xu, Lixin Guo, Qi Pan
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • EndoGene database: reported genetic variants for 5,926 Russian patients diagnosed with endocrine disorders
    Anton A. Buzdin, Marianna A. Zolotovskaia, Sergey A. Roumiantsev, Aleksandra G. Emelyanova, Olga O. Golounina, Polina A. Pugacheva, Daniil V. Luppov, Anastasia V. Kuzminyh, Arseniya O. Alexeeva, Anna A. Emelianova, Alexey L. Novoselov, Alina Matrosova, An
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
Close layer
Original Articles
Miscellaneous
The Status and Distinct Characteristics of Endocrine Diseases in North Korean Articles Published between 2006 and 2015
Kyeong Jin Kim, Shin Ha, Yo Han Lee, Jung Hyun Noh, Sin Gon Kim
Endocrinol Metab. 2018;33(2):268-272.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.268
  • 8,400 View
  • 52 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Past decades of division have led to substantial differences in medical environments between South and North Korea. However, little is known about North Korea's medical status and research field, especially regarding endocrinology. In this study, we report the characteristics of North Korea's articles regarding endocrine-related diseases.

Methods

Among the nine medical journals, articles published in Internal Medicine between 2006 and 2015 were reviewed. A total of 2,092 articles were included; among them, 96 articles were associated with endocrinology. We analyzed these articles according to the disease categories they focused on and evaluated their features.

Results

Articles related to diabetes mellitus accounted for 55.2% (n=53) and those to thyroid disease accounted for 28.1% (n=27). Other disease categories, including adrenal gland (n=1), pituitary gland (n=1), and osteoporosis (n=3), comprised minor portions. Regarding diabetes mellitus, more than half the articles (n=33) focused on treatment and complications. Experimental studies were conducted with old hypoglycemic drugs or natural substances for the treatment of hyperglycemia. Regarding thyroid disease, articles related to hyperthyroidism were the most common (51.9%, n=14), followed by thyroid nodule/cancer (18.5%, n=5). Unique article features were short length, no figures, and less than five references.

Conclusion

North Korea's endocrinology articles mainly focused on diabetes mellitus and thyroid disease. Persistent studies have been carried out in North Korea with dedication despite the poor medical environment. We hope that this study will be the beginning of mutual medical exchange and collaboration between North and South Korea.

Citations

Citations to this article as recorded by  
  • Surgical Diseases in North Korea: An Overview of North Korean Medical Journals
    Sejin Choi, Taehoon Kim, Soyoung Choi, Hee Young Shin
    International Journal of Environmental Research and Public Health.2020; 17(24): 9346.     CrossRef
  • Endocrinology and Metabolism Has Been Indexed in MEDLINE: A Major Achievement
    Won-Young Lee
    Endocrinology and Metabolism.2019; 34(2): 138.     CrossRef
Close layer
Clinical Study
Factors Associated with Postoperative Diabetes Insipidus after Pituitary Surgery
Antonio L. Faltado, Anna Angelica Macalalad-Josue, Ralph Jason S. Li, John Paul M. Quisumbing, Marc Gregory Y. Yu, Cecilia A. Jimeno
Endocrinol Metab. 2017;32(4):426-433.   Published online November 21, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.4.426
  • 11,216 View
  • 127 Download
  • 17 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   
Background

Determining risk factors for diabetes insipidus (DI) after pituitary surgery is important in improving patient care. Our objective is to determine the factors associated with DI after pituitary surgery.

Methods

We reviewed records of patients who underwent pituitary surgery from 2011 to 2015 at Philippine General Hospital. Patients with preoperative DI were excluded. Multiple logistic regression analysis was performed and a predictive model was generated. The discrimination abilities of the predictive model and individual variables were assessed using the receiving operator characteristic curve.

Results

A total of 230 patients were included. The rate of postoperative DI was 27.8%. Percent change in serum Na (odds ratio [OR], 1.39; 95% confidence interval [CI], 1.15 to 1.69); preoperative serum Na (OR, 1.19; 95% CI, 1.02 to 1.40); and performance of craniotomy (OR, 5.48; 95% CI, 1.60 to 18.80) remained significantly associated with an increased incidence of postoperative DI, while percent change in urine specific gravity (USG) (OR, 0.53; 95% CI, 0.33 to 0.87) and meningioma on histopathology (OR, 0.05; 95% CI, 0.04 to 0.70) were significantly associated with a decreased incidence. The predictive model generated has good diagnostic accuracy in predicting postoperative DI with an area under curve of 0.83.

Conclusion

Greater percent change in serum Na, preoperative serum Na, and performance of craniotomy significantly increased the likelihood of postoperative DI while percent change in USG and meningioma on histopathology were significantly associated with a decreased incidence. The predictive model can be used to generate a scoring system in estimating the risk of postoperative DI.

Citations

Citations to this article as recorded by  
  • Cerebral salt wasting syndrome as a probable cause of postoperative polyuria in patients with supratentorial Non-midline tumors: A prospective observational study with targeted and quantitative metabolomic approach
    Lei Shi, Yu-Fang Wang, Guo-Feng Zhang, Yan Li, Ming-Li Yao, Jing-Chao Li, Chun-Fang Qiu, Shun Yao, Bin Ouyang, Ling-Yan Wang
    Neurosurgical Review.2025;[Epub]     CrossRef
  • Perioperative Complications Associated with Routine Preoperative Glucocorticoid Use among Patients undergoing Pituitary Surgery with Normal Preoperative HPA Axis
    Franz Michael Magnaye, Elizabeth Paz-Pacheco
    Journal of the ASEAN Federation of Endocrine Societies.2025;[Epub]     CrossRef
  • Post-operative outcomes of Pituitary Macroadenoma Patients in a Tertiary Hospital in the Philippines
    Mary Angeline Luz Hernandez, Denise Joy Lopez, Jian Narag, Kenny Seng, Kathleen Joy Khu
    Journal of the ASEAN Federation of Endocrine Societies.2025;[Epub]     CrossRef
  • Importance of Intraoperative Factors in Postoperative Arginine Vasopressin Deficiency After Pituitary Adenoma Surgery
    Nasim Alidaei, Guive Sharifi, Zahra Davoudi
    Endocrine Practice.2024; 30(3): 253.     CrossRef
  • Incidence of post-operative diabetes insipidus and associated factors after pituitary surgery in two teaching hospitals, in Addis Ababa, Ethiopia: A prospective observational study
    Abera Chanie, Abat Sahlu
    Interdisciplinary Neurosurgery.2024; 37: 101978.     CrossRef
  • Pituitary Adenoma in the Philippines: A Scoping Review on the Treatment Gaps, Challenges, and Current State of Care
    Mykha Marie B. Tabuzo, Mary Angeline Luz U. Hernandez, Annabell E. Chua, Patricia D. Maningat, Harold Henrison C. Chiu, Roland Dominic G. Jamora
    Medical Sciences.2024; 12(1): 16.     CrossRef
  • In Reply to the Letter to the Editor Regarding “Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study”
    Marcos Ezequiel Yasuda, Daniela Renedo, Rodolfo Recalde, Roberto Zaninovich, Santiago Gonzalez Abbati, Andrés Cervio, Sebastian Giovannini, Juan Villalonga, Liezel Ulloque-Caamaño, Kesava Reddy, Mariano Socolovsky, Alvaro Campero
    World Neurosurgery.2024; 185: 484.     CrossRef
  • Letter to the Editor Regarding “Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study”
    Karlos Acurio, Fritz Fidel Váscones-Román, Fernando Canazas-Paredes, Aryan Wadhwa, Niels Pacheco-Barrios
    World Neurosurgery.2024; 185: 483.     CrossRef
  • Correlation of Pituitary Descent and Diabetes Insipidus After Transsphenoidal Pituitary Macroadenoma Resection
    Josh Ma, Peter Gooderham, Ryojo Akagami, Serge Makarenko
    Neurosurgery.2023; 92(6): 1269.     CrossRef
  • Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study
    Marcos Ezequiel Yasuda, Daniela Renedo, Soledad Sosa, Karina Danilowicz, Rodolfo Recalde, Roberto Zaninovich, Santiago Gonzalez Abbati, Andrés Cervio, Sebastian Giovannini, Juan Villalonga, Liezel Ulloque-Caamaño, Kesava Reddy, Mariano Socolovsky, Alvaro
    World Neurosurgery.2023; 175: e636.     CrossRef
  • Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma
    Kunzhe Lin, Kaichun Fan, Shuwen Mu, Shousen Wang
    European Journal of Medical Research.2022;[Epub]     CrossRef
  • Change in the pituitary stalk deviation angle after transsphenoidal surgery can predict the development of diabetes insipidus for pituitary adenomas
    Liang Xue, Jianwu Wu, Jie Chen, Yongkai Yang
    Endocrine Connections.2022;[Epub]     CrossRef
  • Disorders of Salt and Water Balance After Pituitary Surgery
    Emily K Brooks, Warrick J Inder
    The Journal of Clinical Endocrinology & Metabolism.2022; 108(1): 198.     CrossRef
  • Postoperative diabetes insipidus: how to define and grade this complication?
    Friso de Vries, Daniel J. Lobatto, Marco J. T. Verstegen, Wouter R. van Furth, Alberto M. Pereira, Nienke R. Biermasz
    Pituitary.2021; 24(2): 284.     CrossRef
  • Diaphragma sellae sinking can predict the onset of hyponatremia after transsphenoidal surgery for pituitary adenomas
    Kunzhe Lin, Jun Li, Lingling Lu, Shangming Zhang, Shuwen Mu, Zhijie Pei, Cheng Wang, Jingying Lin, Liang Xue, Liangfeng Wei, Lin Zhao, Shousen Wang
    Journal of Endocrinological Investigation.2021; 44(11): 2511.     CrossRef
  • Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma
    Ujjwala Murkute
    Indian Journal of Continuing Nursing Education.2021; 22(2): 137.     CrossRef
  • Sodium Perturbations After Pituitary Surgery
    Kevin C.J. Yuen, Adnan Ajmal, Ricardo Correa, Andrew S. Little
    Neurosurgery Clinics of North America.2019; 30(4): 515.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP